BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17242364)

  • 1. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo.
    Regoes RR; Barber DL; Ahmed R; Antia R
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1599-603. PubMed ID: 17242364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating CTL mediated killing with a 3D cellular automaton.
    Graw F; Regoes RR
    PLoS Comput Biol; 2009 Aug; 5(8):e1000466. PubMed ID: 19696876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Sigmoid Functional Response Emerges When Cytotoxic T Lymphocytes Start Killing Fresh Target Cells.
    Gadhamsetty S; Marée AFM; Beltman JB; de Boer RJ
    Biophys J; 2017 Mar; 112(6):1221-1235. PubMed ID: 28355549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.
    Hogan T; Kadolsky U; Tung S; Seddon B; Yates A
    PLoS Comput Biol; 2014 Sep; 10(9):e1003805. PubMed ID: 25233372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells.
    Hahn K; DeBiasio R; Tishon A; Lewicki H; Gairin JE; LaRocca G; Taylor DL; Oldstone M
    Virology; 1994 Jun; 201(2):330-40. PubMed ID: 8184542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of specific cytotoxic T lymphocyte killing.
    Clemente T; Dominguez MR; Vieira NJ; Rodrigues MM; Amarante-Mendes GP
    Methods; 2013 Jun; 61(2):105-9. PubMed ID: 23454288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
    Halle S; Halle O; Förster R
    Trends Immunol; 2017 Jun; 38(6):432-443. PubMed ID: 28499492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
    Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
    Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.
    Halle S; Keyser KA; Stahl FR; Busche A; Marquardt A; Zheng X; Galla M; Heissmeyer V; Heller K; Boelter J; Wagner K; Bischoff Y; Martens R; Braun A; Werth K; Uvarovskii A; Kempf H; Meyer-Hermann M; Arens R; Kremer M; Sutter G; Messerle M; Förster R
    Immunity; 2016 Feb; 44(2):233-45. PubMed ID: 26872694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells.
    Gadhamsetty S; Marée AF; Beltman JB; de Boer RJ
    Biophys J; 2014 Apr; 106(8):1780-91. PubMed ID: 24739177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
    Mandl JN; Regoes RR; Garber DA; Feinberg MB
    J Virol; 2007 Nov; 81(21):11982-91. PubMed ID: 17699572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?
    Wick WD; Yang OO; Corey L; Self SG
    J Virol; 2005 Nov; 79(21):13579-86. PubMed ID: 16227278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data.
    Beck RJ; Bijker DI; Beltman JB
    PLoS Comput Biol; 2020 Jul; 16(7):e1007972. PubMed ID: 32658891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.